News Highlights: Top Company News of the Day
April 25 2019 - 1:30PM
Dow Jones News
Amgen, Astellas to Pay $125 Million to Settle Kickback Claims
Amgen and Astellas Pharma's U.S. unit have agreed to pay a total
of $125 million to resolve kickback allegations that they violated
federal law by using charities to pay for Medicare patients'
out-of-pocket costs for the companies' own drugs.
Verizon Pauses Plans to Charge for 5G
The carrier is holding off for now on plans to charge an extra
$10 a month for faster 5G smartphone service, after some analysts
criticized its limited scope. Verizon had said earlier that it
would impose the fee after three months.
Alibaba's Taobao.com Stays on 'Notorious Markets' List
U.S. trade officials acknowledged steps by China's Alibaba to
curb the sale of counterfeit goods on its Taobao.com platform but
left the e-commerce site on its "notorious markets" list.
Facebook Probe Found Major Shortcomings in Privacy Protection, Watchdog Says
Canada's privacy watchdog said a probe found Facebook broke the
country's privacy laws and failed to protect Canadians' personal
information, and will go to court to force the social-media company
to fix the deficiencies.
Microsoft Hits $1 Trillion Market Value for First Time
Shares of Microsoft topped the $130.50 value needed to give the
company a market value of $1 trillion, joining Apple and Amazon.com
as the only U.S. companies to ever reach that mark.
Southwest's MAX Groundings Cut Flight-Capacity Growth
Southwest Airlines Co. said the grounding of its Boeing Co. 737
MAX planes will cut flight-capacity growth and push up costs in the
coming months. The airline said it expects to expand its flight
capacity by between 2% and 3% this year, compared with growth of as
much as 5% previously.
Carlos Ghosn Leaves Jail Again
Former Nissan Motor Chairman Carlos Ghosn left a Tokyo jail late
Thursday after being granted bail by a court in Tokyo, agreeing to
strict conditions such as not contacting his wife unless the court
approves.
Eli Lilly to Pull Cancer Drug From Market After Failed Study
Eli Lilly plans to withdraw its cancer drug Lartruvo from the
market after a study showed that it failed to prolong overall
survival in a clinical trial.
Deutsche Bank and Rival Commerzbank End Merger Talks
Banking giant Deutsche Bank and crosstown rival Commerzbank
ended merger talks, leaving in tatters the German government's hope
create a banking powerhouse.
Altria Net Falls 40% on Smaller Revenue, Bigger Expenses
Altria Group reported a 40% drop in net income for the latest
quarter, as revenue declined and it booked several charges related
to its expansion efforts.
(END) Dow Jones Newswires
April 25, 2019 13:15 ET (17:15 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.